SEC Form 4 · Updated Daily
CYTK
— CYTOKINETICS, INCORPORATED OwnershipInsider and institutional ownership derived from SEC Form 4 filings. Click any owner to see their holdings across every company they’ve filed on, and how their position has changed over time.
Current Reporting Owners
| Owner | Role | Shares Owned | As Of | Last Activity |
|---|---|---|---|---|
| SCHMERTZLER MICHAEL | Director | 4,340,923 | 2010-06-03 | S |
| BVF PARTNERS L P/IL | 10%+ Owner | 3,811,271 | 2020-12-09 | S |
| BIOTECHNOLOGY VALUE FUND L P | 10%+ Owner | 3,811,271 | 2020-12-09 | S |
| BVF I GP LLC | 10%+ Owner | 3,811,271 | 2020-12-09 | S |
| BIOTECHNOLOGY VALUE FUND II LP | Reporting Owner | 3,811,271 | 2020-12-09 | S |
| BVF II GP LLC | Reporting Owner | 3,811,271 | 2020-12-09 | S |
| Biotechnology Value Trading Fund OS LP | Reporting Owner | 3,811,271 | 2020-12-09 | S |
| BVF Partners OS Ltd. | Reporting Owner | 3,811,271 | 2020-12-09 | S |
| BVF GP HOLDINGS LLC | 10%+ Owner | 3,811,271 | 2020-12-09 | S |
| BVF INC/IL | 10%+ Owner | 3,811,271 | 2020-12-09 | S |
| LAMPERT MARK N | 10%+ Owner | 3,811,271 | 2020-12-09 | S |
| Portfolio Services Ltd. | 10%+ Owner | 2,883,845 | 2014-02-25 | P |
| Eastern Capital LTD | 10%+ Owner | 2,883,845 | 2014-02-25 | P |
| DART KENNETH BRYAN | 10%+ Owner | 2,883,845 | 2014-02-25 | P |
| DOW STEPHEN M | 10%+ Owner · Director | 1,421,052 | 2012-11-14 | S |
| Blum Robert I | Director · Officer | 286,044 | 2026-10-12 | M |
| SPUDICH JAMES A | Director | 181,800 | 2008-04-25 | S |
| Malik Fady Ibraham | Officer | 157,402 | 2026-10-20 | M |
| Cragg David | Officer | 153,233 | 2022-03-07 | F |
| SCHLOSSBERG MARK A | Officer | 128,604 | 2022-03-15 | M |
| Hessekiel Jeffrey | Officer | 107,943 | 2026-03-15 | A |
| Jaw Ching | Officer | 87,346 | 2023-03-06 | A |
| HENDERSON JOHN T | Director | 78,712 | 2026-10-16 | A |
| Callos Andrew | Officer | 68,555 | 2026-08-31 | M |
| Morgan Bradley Paul | Officer | 67,645 | 2017-08-31 | M |
| Lee Sung | Officer | 64,333 | 2026-07-01 | M |
| GAGE L PATRICK | Director | 51,234 | 2021-11-08 | M |
| MORGANS DAVID J JR | Officer | 48,734 | 2009-10-01 | S |
| TRAUTMAN JAY K | Officer | 47,896 | 2007-08-10 | M |
| BARBARI SHARON SURREY | Director | 47,640 | 2017-02-28 | A |
| WOLFF ANDREW A | Officer | 47,255 | 2017-02-28 | A |
| Schnieders Elisabeth | Officer | 43,919 | 2017-02-28 | A |
| WIERENGA WENDELL | Director | 35,660 | 2026-10-16 | A |
| McDowell Caryn Gordon | Officer | 35,000 | 2018-02-27 | A |
| Wysenski Nancy | Director | 34,089 | 2026-10-16 | A |
| Pletcher Brett A | Officer | 33,140 | 2024-08-30 | A |
| WIERENGA WENDALL D | Officer | 32,345 | 2025-07-15 | A |
| CHARPENTIER BONNIE | Officer | 29,004 | 2017-02-28 | A |
| Bhanji Muna | Director | 26,361 | 2026-05-27 | A |
| Sabry James H | Reporting Owner | 25,000 | 2010-06-03 | M |
| Harrington Robert Arthur | Director | 22,127 | 2026-10-16 | A |
| RODDY PETER S | Officer | 21,520 | 2018-02-27 | A |
| COSTA SANTO J | Director | 20,600 | 2024-05-15 | A |
| RABSON MICHAEL | Officer | 20,043 | 2009-12-18 | M |
| SMITH SANDFORD D | Director | 18,801 | 2024-01-02 | A |
| Wong Robert | Officer | 18,655 | 2024-12-03 | A |
| PARSHALL B LYNNE | Director | 10,784 | 2026-09-01 | S |
| Kaye Edward M. MD | Director | 10,629 | 2026-10-16 | A |
| Landry Robert E | Director | 8,184 | 2026-09-15 | S |
| Califf Robert | Director | 6,003 | 2022-01-03 | A |
| Daly James M | Director | 3,585 | 2026-10-16 | A |
Recent Filings
| Date | Owner | Activity | Shares | Price | Owned After |
|---|---|---|---|---|---|
| 2026-10-20 | Malik Fady Ibraham | Option exercise (derivative) | 3,500 | $0.00 | 16,386 |
| 2026-10-20 | Malik Fady Ibraham | Open-market sale | 3,500 | $64.01 | 153,902 |
| 2026-10-20 | Malik Fady Ibraham | Option exercise | 3,500 | $7.80 | 157,402 |
| 2026-10-16 | HENDERSON JOHN T | Grant / award | 352 | $63.92 | 78,712 |
| 2026-10-16 | WIERENGA WENDELL | Grant / award | 97 | $63.92 | 35,660 |
| 2026-10-16 | Daly James M | Grant / award | 195 | $63.92 | 3,585 |
| 2026-10-16 | Harrington Robert Arthur | Grant / award | 195 | $63.92 | 22,127 |
| 2026-10-16 | Kaye Edward M. MD | Grant / award | 195 | $63.92 | 10,629 |
| 2026-10-16 | Wysenski Nancy | Grant / award | 97 | $63.92 | 34,089 |
| 2026-10-12 | Blum Robert I | Option exercise (derivative) | 7,500 | $0.00 | 141,745 |
| 2026-10-12 | Blum Robert I | Open-market sale | 7,500 | $62.88 | 278,544 |
| 2026-10-12 | Blum Robert I | Option exercise | 7,500 | $10.60 | 286,044 |
| 2026-10-06 | Malik Fady Ibraham | Option exercise (derivative) | 3,500 | $0.00 | 19,886 |
| 2026-10-06 | Malik Fady Ibraham | Open-market sale | 3,500 | $61.38 | 153,902 |
| 2026-10-06 | Malik Fady Ibraham | Option exercise | 3,500 | $7.80 | 157,402 |
| 2026-09-28 | Blum Robert I | Option exercise (derivative) | 7,500 | $0.00 | 149,245 |
| 2026-09-28 | Blum Robert I | Open-market sale | 7,500 | $65.46 | 278,544 |
| 2026-09-28 | Blum Robert I | Option exercise | 7,500 | $10.60 | 286,044 |
| 2026-09-22 | Malik Fady Ibraham | Option exercise (derivative) | 3,500 | $0.00 | 23,386 |
| 2026-09-22 | Malik Fady Ibraham | Open-market sale | 3,500 | $68.29 | 153,902 |
| 2026-09-22 | Malik Fady Ibraham | Option exercise | 3,500 | $7.80 | 157,402 |
| 2026-09-15 | Blum Robert I | Open-market sale | 97,926 | $69.33 | 0 |
| 2026-09-15 | Landry Robert E | Open-market sale | 1,000 | $72.13 | 8,184 |
| 2026-09-14 | Blum Robert I | Option exercise (derivative) | 7,500 | $0.00 | 156,745 |
| 2026-09-14 | Blum Robert I | Gift | 97,926 | $0.00 | 97,926 |
| 2026-09-14 | Blum Robert I | Gift | 97,926 | $0.00 | 278,544 |
| 2026-09-14 | Blum Robert I | Gift | 1,350 | $0.00 | 376,470 |
| 2026-09-14 | Blum Robert I | Open-market sale | 7,500 | $73.44 | 377,820 |
| 2026-09-14 | Blum Robert I | Option exercise | 7,500 | $10.60 | 385,320 |
| 2026-09-11 | Landry Robert E | Open-market sale | 1,000 | $74.66 | 9,184 |
| 2026-09-08 | Malik Fady Ibraham | Option exercise (derivative) | 3,500 | $0.00 | 26,886 |
| 2026-09-08 | Malik Fady Ibraham | Open-market sale | 3,500 | $75.46 | 153,902 |
| 2026-09-08 | Malik Fady Ibraham | Option exercise | 3,500 | $7.80 | 157,402 |
| 2026-09-01 | PARSHALL B LYNNE | Open-market sale | 5,000 | $71.48 | 10,784 |
| 2026-08-31 | Blum Robert I | Option exercise (derivative) | 7,500 | $0.00 | 164,245 |
| 2026-08-31 | Blum Robert I | Open-market sale | 7,500 | $70.24 | 377,820 |
| 2026-08-31 | Blum Robert I | Option exercise | 7,500 | $10.60 | 385,320 |
| 2026-08-31 | Callos Andrew | Option exercise (derivative) | 10,000 | $0.00 | 0 |
| 2026-08-31 | Callos Andrew | Open-market sale | 10,000 | $70.24 | 58,555 |
| 2026-08-31 | Callos Andrew | Option exercise | 10,000 | $23.26 | 68,555 |
Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.